Related Experiment Video
Updated: May 6, 2026
Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
Somatic mutation of CDKN1B in small intestine neuroendocrine tumors
Joshua M Francis1, Adam Kiezun, Alex H Ramos
11] Broad Institute, Cambridge, Massachusetts, USA. [2] Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. [3].
Abstract:
The diagnosed incidence of small intestine neuroendocrine tumors (SI-NETs) is increasing, and the underlying genomic mechanisms have not yet been defined. Using exome- and genome-sequence analysis of SI-NETs, we identified recurrent somatic mutations and deletions in CDKN1B, the cyclin-dependent kinase inhibitor gene, which encodes p27. We observed frameshift mutations of CDKN1B in 14 of 180 SI-NETs, and we detected hemizygous deletions encompassing CDKN1B in 7 out of 50 SI-NETs, nominating p27 as a tumor suppressor and implicating cell cycle dysregulation in the etiology of SI-NETs.
Insights
Small intestine neuroendocrine tumors (SI-NETs) show increasing incidence. Genomic analysis reveals mutations and deletions in the CDKN1B gene, encoding p27, suggesting cell cycle dysregulation in SI-NET development.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- The incidence of small intestine neuroendocrine tumors (SI-NETs) is rising globally.
- The specific genetic drivers of SI-NETs remain largely undefined.
- Understanding the genomic landscape is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the genomic alterations underlying the development of SI-NETs.
- To identify key genes and pathways involved in SI-NET tumorigenesis.
- To explore the role of cell cycle regulation in SI-NETs.
Main Methods:
- Whole exome and genome sequencing of SI-NET patient samples.
- Analysis of somatic mutations and copy number variations.
- Identification of recurrently altered genes, including CDKN1B.
Main Results:
- Recurrent somatic mutations and deletions were identified in the CDKN1B gene.
- Frameshift mutations in CDKN1B were found in 14 out of 180 SI-NETs.
- Hemizygous deletions of CDKN1B were detected in 7 out of 50 SI-NETs.
Conclusions:
- The gene CDKN1B, encoding the cell cycle inhibitor p27, acts as a tumor suppressor in SI-NETs.
- Dysregulation of the cell cycle, specifically involving p27, is implicated in the etiology of SI-NETs.
- These findings provide novel insights into the molecular pathogenesis of SI-NETs.
Related Concept Videos
02:21Cancers Originate from Somatic Mutations in a Single Cell
02:21Cancers Originate from Somatic Mutations in a Single Cell
02:34Inhibition of Cdk Activity
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
02:15M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...